Schiller N L, Joiner K A
Infect Immun. 1986 Dec;54(3):689-94. doi: 10.1128/iai.54.3.689-694.1986.
The interaction of complement with the following two strains of Pseudomonas aeruginosa was examined: 144M, a mucoid, serum-sensitive strain bearing short lipopolysaccharide O chains, and 144M-SR, a mucoid, serum-resistant strain bearing long lipopolysaccharide O chains isolated by repeated passage of 144M in increasing concentrations of pooled normal human serum (PNHS). While significant killing of 144M occurred in 5 to 40% PNHS, no killing of 144M-SR was observed. Both strains activated complement, especially 144M-SR which consumed 88.7, 96.4, and 100% of the available complement 3 (C3), C5, and C9, respectively, in 10% PNHS during a 60-min incubation at 37 degrees C. Although it activated more C3 than did 144M (54.9% consumption), 144M-SR bound only half as much C3 as 144M. Similarly, although 144M-SR activated more C9 than did 144M (50.0% consumption in 60 min), there was considerably less C9 attached to 144M-SR (2,990 molecules of C9 per bacterium) than to 144M (13,700 molecules per bacterium) after 60 min of incubation. Furthermore, only 162 molecules of the C9 bound to 144M-SR remained bound after treatment with 0.1% trypsin, while 5,692 molecules of the C9 bound to 144M remained bound under similar conditions. These results show that the serum resistance of 144M-SR does not represent a failure to activate complement efficiently, but instead reflects failure of the assembled terminal complement complex C5b-9 to insert stably into the outer membrane of this strain.
144M,一株黏液型、血清敏感菌株,带有短脂多糖O链;以及144M-SR,一株黏液型、血清抗性菌株,带有通过将144M在浓度递增的混合正常人血清(PNHS)中反复传代分离得到的长脂多糖O链。虽然在5%至40%的PNHS中144M出现了显著的杀伤,但未观察到144M-SR被杀伤。两株菌株均能激活补体,尤其是144M-SR,在37℃孵育60分钟期间,它在10%的PNHS中分别消耗了88.7%、96.4%和100%的可用补体3(C3)、C5和C9。尽管144M-SR比144M激活了更多的C3(消耗54.9%),但其结合的C3仅为144M的一半。同样,尽管144M-SR比144M激活了更多的C9(60分钟内消耗50.0%),但孵育60分钟后,附着在144M-SR上的C9(每细菌2990个C9分子)比附着在144M上的(每细菌13700个分子)少得多。此外,用0.1%胰蛋白酶处理后,与144M-SR结合的C9中只有162个分子仍保持结合,而在类似条件下,与144M结合的C9中有5692个分子仍保持结合。这些结果表明,144M-SR的血清抗性并非代表不能有效地激活补体,而是反映了组装好的末端补体复合物C5b-9未能稳定地插入该菌株的外膜。